Screening for trisomy 21 based on maternal age, nuchal translucency measurement, first trimester biochemistry and quantitative and qualitative assessment of the flow in the DV — the assessment of efficacy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.